CoA pathway genes
bacterial CoA biosynthesis pathway of Mycobacterium tuberculosis
antimicrobial drug
Mtb CoaBC
potent inhibitors of targets
vulnerable enzyme target
conserved biosynthesis pathway of Coenzyme
small molecule CoaBC inhibitors
multiple pathogenic microorganisms
resistant microorganisms
shortage of novel antimicrobial chemotherapeutics
Antimicrobial chemotherapies
novel modes of action
increasing prevalence of drug
limited diversity of high
high failure rate
essential enzyme cofactor
cell-active leads
throughput screening libraries
difficulties
conditional knockdown mutants
efficient approach
capacity
formidable task
pipeline
infectious diseases
confirming
experiments
research
panel
serious threat
initial efforts
cross-species activity
approaches
antibiotics
series
fragment
Cambridge
development
pathogens
addition